Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAL-Ph-2000 Protocol for Ph+ ALL
NCT00526305Phase 4Completed
- Sponsor
- Fundación PETHEMA
- Start
- Jan 2000
- Primary completion
- Apr 2005
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of vincristine, daunorubicin, prednisone, asparaginase escherichia coli, mitoxantrone in Acute lymphoblastic leukemia, Philadelphia chromosome positive, sponsored by Fundación PETHEMA. Started Jan 2000; status: completed.
02
Drugs
vincristinedaunorubicinprednisoneasparaginase escherichia colimitoxantrone
03
Conditions
Acute lymphoblastic leukemia, Philadelphia chromosome positive
Beyond the preview
Go deeper on NCT00526305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00526305.